Order:
  1. Country Reports.Ma'N. H. Zawati, Don Chalmers, Sueli G. Dallari, Marina de Neiva Borba, Miriam Pinkesz, Yann Joly, Haidan Chen, Mette Hartlev, Liis Leitsalu, Sirpa Soini, Emmanuelle Rial-Sebbag, Nils Hoppe, Tina Garani-Papadatos, Panagiotis Vidalis, Krishna Ravi Srinivas, Gil Siegal, Stefania Negri, Ryoko Hatanaka, Maysa Al-Hussaini, Amal Al-Tabba', Lourdes Motta-Murgía, Laura Estela Torres Moran, Aart Hendriks, Obiajulu Nnamuchi, Rosario Isasi, Dorota Krekora-Zajac, Eman Sadoun, Calvin Ho, Pamela Andanda, Won Bok Lee, Pilar Nicolás, Titti Mattsson, Vladislava Talanova, Alexandre Dosch, Dominique Sprumont, Chien-Te Fan, Tzu-Hsun Hung, Jane Kaye, Andelka Phillips, Heather Gowans, Nisha Shah & James W. Hazel - 2019 - Journal of Law, Medicine and Ethics 47 (4):582-704.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  2.  14
    Privacy and Biobanking in China: A Case of Policy in Transition.Haidan Chen, Benny Chan & Yann Joly - 2015 - Journal of Law, Medicine and Ethics 43 (4):726-742.
    With a population of over 1.3 billion, China is the most populous country in the world. It is facing an acute aging population problem, with a projected 440 million residents over age 60 and 101 million over age 80 by 2050. Furthermore, rapid industrialization and urbanization in China have resulted in serious air pollution and associated public health problems, including an increase in respiratory diseases and cancers. These and other demographic trends have generated concerns about the cost of health care (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  3.  38
    Stem Cell Treatments in China: Rethinking the Patient Role in the Global Bio‐Economy.Haidan Chen & Herbert Gottweis - 2013 - Bioethics 27 (4):194-207.
    The paper looks in detail at patients that were treated at one of the most discussed companies operating in the field of untried stem cell treatments, Beike Biotech of Shenzhen, China. Our data show that patients who had been treated at Beike Biotech view themselves as proactively pursuing treatment choices that are not available in their home countries. These patients typically come from a broad variety of countries: China, the United Kingdom, the United States, South Africa and Australia. Among the (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark  
  4.  5
    Pragmatic Commitments to Naturalized Epistemology.Hangqing Cong, Xiaodong Cheng & Haidan Chen - 2006 - Frontiers of Philosophy in China 1 (3):477-490.
    This essay explores numerous and complicated naturalized epistemology against the background of pragmatism. We distinguish three programmes of naturalized epistemology: strong, moderate, and weak. By considering commitments of pragmatism on which different programmes depend, we point out the close-knit relationship between pragmatism and naturalized epistemology. We also illustrate the essential origin of today's controversy over naturalized epistemology and predict the uptrend of naturalized epistemology.
    No categories
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  5.  3
    Public Involvement in the Governance of Population-Level Biomedical Research: Unresolved Questions and Future Directions.Sonja Erikainen, Phoebe Friesen, Leah Rand, Karin Jongsma, Michael Dunn, Annie Sorbie, Matthew McCoy, Jessica Bell, Michael Burgess, Haidan Chen, Vicky Chico, Sarah Cunningham-Burley, Julie Darbyshire, Rebecca Dawson, Andrew Evans, Nick Fahy, Teresa Finlay, Lucy Frith, Aaron Goldenberg, Lisa Hinton, Nils Hoppe, Nigel Hughes, Barbara Koenig, Sapfo Lignou, Michelle McGowan, Michael Parker, Barbara Prainsack, Mahsa Shabani, Ciara Staunton, Rachel Thompson, Kinga Varnai, Effy Vayena, Oli Williams, Max Williamson, Sarah Chan & Mark Sheehan - forthcoming - Journal of Medical Ethics:medethics-2020-106530.
    Population-level biomedical research offers new opportunities to improve population health, but also raises new challenges to traditional systems of research governance and ethical oversight. Partly in response to these challenges, various models of public involvement in research are being introduced. Yet, the ways in which public involvement should meet governance challenges are not well understood. We conducted a qualitative study with 36 experts and stakeholders using the World Café method to identify key governance challenges and explore how public involvement can (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  6.  1
    Privacy and Biobanking in China: A Case of Policy in Transition.Haidan Chen, Benny Chan & Yann Joly - 2015 - Journal of Law, Medicine and Ethics 43 (4):726-742.
    With a population of over 1.3 billion, China is the most populous country in the world. It is facing an acute aging population problem, with a projected 440 million residents over age 60 and 101 million over age 80 by 2050. Furthermore, rapid industrialization and urbanization in China have resulted in serious air pollution and associated public health problems, including an increase in respiratory diseases and cancers. These and other demographic trends have generated concerns about the cost of health care (...)
    No categories
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark